CHOKSHI S ET AL: "CHARACTERIZATION OF ANTIVIRAL ACTIVITIES OF CYCLOPHILIN INHIBITORS DEB025 (ALISPORIVIR) AND NIM811 ON HEPATITIS B VIRUS (HBV) REPLICATION AND HBSAG SECRETION IN VITRO", JOURNAL OF HEPATOLOGY, vol. 54, no. Suppl. 1, March 2011 (2011-03), pages S437-S438, XP002680374, & 46TH ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-THE- LIVER (EASL); BERLIN, GERMANY; MARCH 30 -APRIL 03, 2011 ISSN: 0168-8278 (B1)

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER: "EASL Clinical Practice Guidelines: Management of chronic hepatitis B", JOURNAL OF HEPATOLOGY, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, vol. 50, no. 2, 1 February 2009 (2009-02-01), pages 227-242, XP025769996, ISSN: 0168-8278, DOI: 10.1016/J.JHEP.2008.10.001 [retrieved on 2008-10-29] cited in the application (B1)

WO-A1-2006/038088 (B1)

LOGUIDICE AMANDA ET AL: "Acetaminophen overdose-induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D-regulated permeability transition.", HEPATOLOGY (BALTIMORE, MD.) 2 SEP 2011 LNKD- DOI:10.1002/HEP.24464 PUBMED:21626531, vol. 54, no. 3, 2 September 2011 (2011-09-02), pages 969-978, XP002680376, ISSN: 1527-3350 (B1)

PHILLIPS S ET AL: "ALISPORIVIR-INDUCED INHIBITION OF CELLULAR CYCLOPHILINS DISRUPTS HEPATITIS B VIRUS (HBV) REPLICATION IN VITRO AND IS SYNERGISTIC IN COMBINATION WITH DIRECT ANTIVIRAL TARGETING HBV-DNA POLYMERASE", JOURNAL OF HEPATOLOGY, vol. 56, no. Suppl. 2, April 2012 (2012-04), pages S199-S200, XP002680375, & 47TH ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-THE- LIVER (EASL); BARCELONA, SPAIN; APRIL 18 -22, 2012 ISSN: 0168-8278 (B1)

INOUE KAZUAKI ET AL: "Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.", HEPATOLOGY (BALTIMORE, MD.) APR 2007 LNKD- PUBMED:17393519, vol. 45, no. 4, April 2007 (2007-04), pages 921-928, XP002680373, ISSN: 0270-9139 (B1)